Detalhe da pesquisa
1.
COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022.
Mult Scler
; 30(3): 381-395, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38247113
2.
Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society.
Mult Scler
; : 13524585231223880, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38357870
3.
The radiologically isolated syndrome: revised diagnostic criteria.
Brain
; 146(8): 3431-3443, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36864688
4.
Impact of COVID-19 vaccination or infection on disease activity in a radiologically isolated syndrome cohort: The VaxiRIS study.
Mult Scler
; 29(9): 1099-1106, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37322880
5.
Pregnancy and multiple sclerosis: 2022 recommendations from the French multiple sclerosis society.
Mult Scler
; 29(1): 11-36, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36317497
6.
Pregnancy and neuromyelitis optica spectrum disorders: 2022 recommendations from the French Multiple Sclerosis Society.
Mult Scler
; 29(1): 37-51, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36345839
7.
Relevance of kappa free light chains index in patients with aquaporin-4 or myelin-oligodendrocyte-glycoprotein antibodies.
Eur J Neurol
; 30(9): 2865-2869, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37243935
8.
Post-vaccine COVID-19 in patients with multiple sclerosis or neuromyelitis optica.
Mult Scler
; 28(7): 1155-1159, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34931885
9.
Prospective longitudinal study on prognostic factors of visual recovery and structural change after a first episode of optic neuritis.
Eur J Neurol
; 29(9): 2781-2791, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35617154
10.
Visual field loss and structure-function relationships in optic neuritis associated with myelin oligodendrocyte glycoprotein antibody.
Mult Scler
; 27(6): 855-863, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32633601
11.
Multiple sclerosis: Is there a risk of worsening after yellow fever vaccination?
Mult Scler
; 27(14): 2280-2283, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33870792
12.
Efficacy of rituximab in refractory RRMS.
Mult Scler
; 25(6): 828-836, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29722639
13.
Abnormal inflammatory activity returns after natalizumab cessation in multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 85(9): 1038-40, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24876183
14.
Natalizumab extended-interval dosing in a real-life setting.
J Neurol Sci
; 450: 120689, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37210938
15.
Acute optic neuritis: What are the clues to the aetiological diagnosis in real life?
Mult Scler Relat Disord
; 76: 104764, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37270881
16.
Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis.
JAMA Netw Open
; 6(6): e2319766, 2023 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37351881
17.
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France.
Ann Clin Transl Neurol
; 8(8): 1738-1744, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34240579
18.
Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated Syndrome.
JAMA Netw Open
; 4(10): e2128271, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34633424
19.
Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis.
JAMA Neurol
; 77(9): 1079-1088, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32589189
20.
Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France.
JAMA Neurol
; 77(1): 94-102, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31479149